A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of Manufacturing Scale 13-valent Pneumococcal Conjugate Vaccine

Registry ID

EUCTR2006-006204-11

Source registry

EUCTR

Phase

PHASE3

Sponsor

Wyeth Research Division of Wyeth Pharmaceuticals Inc.

Start date

2007-06-12

Last update

2026-08-16

Conditions

• Healthy infants

Summary

Primary Objective: • To assess the pneumococcal immune responses induced by manufacturing scale 13vPnC relative to the immune responses induced by pilot scale 13vPnC when measured 1month after the infant series.

Locations

• , , Poland

View on source registry